REFERENCES
- Baeuerle PA, Baltimore D. 1988. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science. 242: 540–546. [PUBMED], [INFOTRIEVE]
- Barry MA, Eastman A. 1992. Endonuclease activation during apoptosis: the role of cytosolic Ca2 + and pH. Biochem Biophys Res Commun. 186: 782–789. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bastola DR, Pahwa GS, et al, 2002. Downregulation of PTEN/MMAC/TEP1 expression in human prostate cancer cell line DU145 by growth stimuli. Mol Cell Biochem. 236: 75–81. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chu ZL, McKinsey TA, et al, 1997. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci USA. 94: 10057–10062. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Colombel M, Symmans F, et al, 1993. Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone- refractory human prostate cancers. Am J Pathol. 143: 390–400. [PUBMED], [INFOTRIEVE]
- Datta SR, Dudek H, et al, 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91: 231–241. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Honda T, Kagawa S, et al, 2002. A recombinant adenovirus expressing wild-type Bax induces apoptosis in prostate cancer cells independently of their Bcl-2 status and androgen sensitivity. Cancer Biol Ther. 1: 163–167. [PUBMED], [INFOTRIEVE], [CSA]
- Huang H, Cheville JC, et al, 2001. PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression. J Biol Chem. 276: 38830–38836. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kimura K, Gelmann EP. 2002. Propapoptotic effects of NF-kappaB in LNCaP prostate cancer cells lead to serine protease activation. Cell Death Differ. 9: 972–980. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kroemer G, Reed JC. 2000. Mitochondrial control of cell death. Nat Med. 6: 513–519. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lee ECY, Zhan P, Schallhorn R, Packman K, Tenniswood M. 2003. Antiandrogen-induced cell death in LNCaP human prostate cancer cells. Cell Death Differ. 10: 761–771. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Li J, Yen C, Liaw D, et al, 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 275: 1943–1947. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Maehama T, Dixon JE. 1999. PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell Biol. 9: 125–128. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Marcelli M, Marani M, et al, 2000. Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members, and caspase activation. Prostate. 42: 260–273. [PUBMED], [INFOTRIEVE], [CROSSREF]
- McEleny KR, Watson RW, et al, 2002. Inhibitors of apoptosis proteins in prostate cancer cell lines. Prostate. 51: 133–140. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mercurio F, Zhu H, et al, 1997. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF- kappaB activation. Science. 278: 860–866. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Morris GZ, Williams RL, et al, 2002. Resveratrol induces apoptosis in LNCaP cells and requires hydroxyl groups to decrease viability in LNCaP and DU 145 cells. Prostate. 52: 319–329. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Munshi A, Pappas G, et al, 2001. TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2. Oncogene. 20: 3757–3765. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nesterov A, Lu X, et al, 2001. Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis. J Biol Chem. 276: 10767–10774. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rokhlin OW, Guseva NV, et al, 2002. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP. Prostate. 52: 1–11. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rothe M, Pan MG, et al, 1995. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 83: 1243–1252. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ruffion A, Al-Sakkaf KA, et al, 2003. The survival effect of prolactin on PC3 prostate cancer cells. Eur Urol. 43: 301–308. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Suh J, Payvandi F, et al, 2002. Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells. Prostate. 52: 183–200. [PUBMED], [INFOTRIEVE], [CROSSREF]
- van Brussel JP, van Steenbrugge GJ, et al, 1999. Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins. Eur J Cancer. 35: 664–671. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Vlietstra RJ, van Alewijk DC, et al, 1998. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res. 58: 2720–2723. [PUBMED], [INFOTRIEVE]
- Wang CY, Mayo MW, et al, 1998. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c- IAP2 to suppress caspase-8 activation. Science. 281: 1680–1683. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yeh JY, Huang WJ, et al, 2003. Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate. 54: 112–124. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Zandi E, Chen Y, Karin M. 1998. Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science. 281: 1360–1363. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Zhan P, Lee ECY, et al, 2002. Induction of invasive phenotype by Casodex in hormone sensitive prostate cancer cells. J Steroid Biochem Mol Biol. 83: 101–111. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]